References
- Chen JS, Sambrook PN (2011) Antiresorptive therapies for osteoporosis: a clinical overview. Nat Rev Endocrinol 8(2):81-91 https://doi.org/10.1038/nrendo.2011.146
- Russell RG, Watts NB, Ebetino FH, Rogersm MJ (2008) Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 19(6):733-759 https://doi.org/10.1007/s00198-007-0540-8
- Benford HL, McGowan NW, Helfrich MH, Nuttall ME, Rogers MJ (2001) Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro. Bone 28(5):465-473 https://doi.org/10.1016/S8756-3282(01)00412-4
- Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T (1999) Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104(10):1363-1374 https://doi.org/10.1172/JCI6800
- Stepan JJ, Alenfeld F, Boivin G, Feyen JH, Lakatos P (2003) Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis. Endocr Regul 37(4):225-238
- Seeman E (2010) Bone morphology in response to alendronate as seen by high-resolution computed tomography: through a glass darkly. J Bone Miner Res 25(12):2553-2557 https://doi.org/10.1002/jbmr.261
- Beck TJ, Lewiecki EM, Miller PD, Felsenberg D, Liu Y, Ding B et al (2008) Effects of denosumab on the geometry of the proximal femur in postmenopausal women in comparison with alendronate. J Clin Densitom 11(3):351-359 https://doi.org/10.1016/j.jocd.2008.04.001
- Hyldstrup L, Jorgensen JT, Sorensen TK, Baeksgaard L (2001) Response of cortical bone to antiresorptive treatment. Calcif Tissue Int 68(3):135-139 https://doi.org/10.1007/s002230001204
- Taniguchi T, Ariji Y, Nozawa M, Naitoh M, Kuroiwa Y, Kurita K et al (2016) Computed tomographic assessment of early changes of the mandible in bisphosphonate-treated patients. Oral Surg Oral Med Oral Pathol Oral Radiol 122(3):362-372 https://doi.org/10.1016/j.oooo.2016.06.002
- Bravenboer N, Papapoulos SE, Holzmann P, Hamdy NA, Netelenbos J, Lips P (1999) Bone histomorphometric evaluation of pamidronate treatment in clinically manifest osteoporosis. Osteoporos Int 9(6):489-493 https://doi.org/10.1007/s001980050175
- Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63(11):1567-1575 https://doi.org/10.1016/j.joms.2005.07.010
- Torres SR, Chen CS, Leroux BG, Lee PP, Hollender LG, Santos EC et al (2012) Mandibular cortical bone evaluation on cone beam computed tomography images of patients with bisphosphonate-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol 113(5):695-703 https://doi.org/10.1016/j.oooo.2011.11.011
- Torres SR, Chen CS, Leroux BG, Lee PP, Hollender LG, Lloid M et al (2015) Mandibular inferior cortical bone thickness on panoramic radiographs in patients using bisphosphonates. Oral Surg Oral Med Oral Pathol Oral Radiol 119(5):584-592 https://doi.org/10.1016/j.oooo.2015.02.005
- Helfen T, Sprecher CM, Eberli U, Gueorguiev B, Muller PE, Richards RG et al (2017) High-resolution tomography-based quantification of cortical porosity and cortical thickness at the surgical neck of the humerus during aging. Calcif Tissue Int 101(3):271-279 https://doi.org/10.1007/s00223-017-0279-y
- Zebaze R, Seeman E (2015) Cortical bone: a challenging geography. J Bone Miner Res 30(1):24-29 https://doi.org/10.1002/jbmr.2419
- Chiandussi S, Biasotto M, Dore F, Cavalli F, Cova MA, Di Lenarda R (2006) Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws. Dentomaxillofac Radiol 35(4):236-243 https://doi.org/10.1259/dmfr/27458726
- Rocha GC, Jaguar GC, Moreira CR, Neves EG, Fonseca FP, Pedreira EN (2012) Radiographic evaluation of maxillofacial region in oncology patients treated with bisphosphonates. Oral Surg Oral Med Oral Pathol Oral Radiol 114(5 Suppl):S19-S25 https://doi.org/10.1016/j.tripleo.2011.08.016
- Arce K, Assael LA, Weissman JL, Markiewicz MR (2009) Imaging findings in bisphosphonate-related osteonecrosis of jaws. J Oral Maxillofac Surg 67(5 Suppl):75-84
- Cardoso CL, Barros CA, Curra C, Fernandes LM, Franzolin SO, Junior JS et al (2017) Radiographic findings in patients with medication-related osteonecrosis of the jaw. Int J Dent 3190301. https://doi.org/10.1155/2017/3190301.
- Hamada H, Matsuo A, Koizumi T, Satomi T, Chikazu D (2014) A simple evaluation method for early detection of bisphosphonate-related osteonecrosis of the mandible using computed tomography. J Craniomaxillofac Surg 42(6):924-929 https://doi.org/10.1016/j.jcms.2014.01.012
- Iwata E, Akashi M, Kishimoto M, Kusumoto J, Hasegawa T, Furudoi S et al (2017) Meaning and limitation of cortical bone width measurement with DentaScan in medication-related osteonecrosis of the jaws. Kobe J Med Sci 62(5):114-119
- Swasty D, Lee JS, Huang JC, Maki K, Gansky SA, Hatcher D et al (2009) Anthropometric analysis of the human mandibular cortical bone as assessed by cone-beam computed tomography. J Oral Maxillofac Surg 67(3):491-500 https://doi.org/10.1016/j.joms.2008.06.089
- Peer A, Khamaisi M (2015) Diabetes as a risk factor for medication-related osteonecrosis of the jaw. J Dent Res 94(2):252-260 https://doi.org/10.1177/0022034514560768
Cited by
- Bisphophonate alterations of the jaw bones in individuals with multiple myeloma vol.49, pp.2, 2018, https://doi.org/10.1259/dmfr.20190155